Podcasts

TOGA Podcast 37

Thoracic Oncology Group of Australasia podcast, hosted by: Associate Professor Michael Franco, Professor Catherine Jones and Dr Diane Pascoe

Revolutionising lung cancer healthcare with A.I: Unlocking the future

How is Artificial intelligence (AI) transforming medicine?

Lung Cancer healthcare professionals are interested in the use of AI in radiology, particularly in early diagnosis leading to better patient outcomes. In this podcast, we will explore how AI can aid in early detection, accurate interpretation of imaging scans and reduce diagnostic errors.

This episode is hosted by Associate Professor Michael Franco, dual trained in medical oncology and palliative care and the digital health director at Monash in Melbourne. He is joined by Professor Catherine Jones Cardiothoracic Radiologist I-Med Radiology and Clinical Director of Radiology at Redland Hospital, Brisbane and an expert on the Cancer Australia Expert Group for National Lung Cancer Screening Program. And accompanied by Dr Diane Pascoe a Consultant Radiologist and Deputy Director of Medical Imaging at Royal Melbourne Hospital.

Play TOGA Podcast 37

More Podcasts

A conversation with Associate Professor Tom John and Professor Ben Solomon where they discuss the increased survival benefits for patients with oncogene driven lung cancer
In this Podcast, Mark Scott talks with Alexandra Golledge about her challenges in diagnosis, searching for the best treatments available, living in a regional area
Prof Nick Pavlakis and Prof Emily Stone join discuss the remarkable advances in screening, diagnosing and treating lung cancer that occurred during 2020.
Dorothy Keefe, CEO of Cancer Australia and Mark Scott discuss the COVID impact on diagnosing and treating lung cancer patients.
A fireside chat with Prunella Blinman, Shankar Siva and our three Preceptees: Anna Lawless, Abhijit Pal and Melanie Rabbets about their experiences, their learnings, what
In this episode, Prof Anna Nowak and A/Prof Steven Kao discuss the emerging treatments for mesothelioma patients and the DREAM3R trial.